[Federal Register Volume 79, Number 82 (Tuesday, April 29, 2014)]
[Notices]
[Pages 23969-23970]
[FR Doc No: 2014-09738]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings 1

    Take notice that the Commission received the following electric
corporate filings:
    Docket Numbers: EC14-77-000.
    Applicants: ESI Ebensburg, Inc., Ebensburg Power Company, Ebensburg
Energy, LLC.
    Description: Amendment to April 17, 2014 Application of ESI
Ebensburg, Inc., et. al. for Approval under Section 203 of the Federal
Power Act and Request for a Shortened Comment Period and Expedited
Consideration.
    Filed Date: 4/21/14.
    Accession Number: 20140421-5233.
    Comments Due: 5 p.m. ET 5/8/14.

    Docket Numbers: EC14-79-000.
    Applicants: ITC Midwest LLC.
    Description: ITC Midwest LLC Application Pursuant to Section 203 of
the Federal Power Act (IPL Battery Assets).
    Filed Date: 4/21/14.
    Accession Number: 20140421-5237.
    Comments Due: 5 p.m. ET 5/12/14.

    Docket Numbers: EC14-80-000.
    Applicants: Energia Sierra Juarez U.S., LLC, INTERGEN N.V.
    Description: Application for Authorization to Transfer
Jurisdictional Facilities Pursuant to Section 203 of the Federal Power
Act and Request for Expedited Treatment.
    Filed Date: 4/22/14.
    Accession Number: 20140422-5145.
    Comments Due: 5 p.m. ET 5/13/14.

    Take notice that the Commission received the following exempt
wholesale generator filings:
    Docket Numbers: EG14-44-000.
    Applicants: Stephens Ranch Wind Energy, LLC.
    Description: Notice of Self Certification of Exempt Wholesale
Generator Status of Stephens Ranch Wind Energy, LLC.
    Filed Date: 4/22/14.
    Accession Number: 20140422-5150.
    Comments Due: 5 p.m. ET 5/13/14.
    Take notice that the Commission received the following electric
rate filings:
    Docket Numbers: ER10-1246-008; ER10-1982-009; ER10-1253-008; ER10-
1252-008; ER13-764-007; ER12-2498-007; ER12-2499-007.
    Applicants: Consolidated Edison Energy, Inc., Consolidated Edison
Company of New York,, CONSOLIDATED EDISON SOLUTIONS INC, CED White
River Solar, LLC, Orange and Rockland Utilities, Inc., Alpaugh 50, LLC,
Alpaugh North, LLC.
    Description: Notice of non-material change status of Consolidated
Edison Energy, Inc., et. al.
    Filed Date: 4/21/14.
    Accession Number: 20140421-5261.
    Comments Due: 5 p.m. ET 5/12/14.

    Docket Numbers: ER10-2994-008; ER10-2822-004; ER10-3158-004; ER10-
3159-003; ER10-1720-004; ER12-308-004; ER10-3162-004; ER10-3161-004.
    Applicants: Iberdrola Renewables, LLC, Atlantic Renewable Projects
II LLC, Dillon Wind LLC, Dry Lake Wind Power, LLC, Dry Lake Wind Power
II LLC, Manzana Wind LLC, Mountain View Power Partners III, LLC, Shiloh
I Wind Project, LLC.
    Description: Supplement to June 28, 2013 Updated Market Power
Analysis for the Southwest Region of Iberdrola Renewables, LLC, et. al.
    Filed Date: 4/22/14.
    Accession Number: 20140422-5177.
    Comments Due: 5 p.m. ET 5/2/14.

    Docket Numbers: ER13-2301-001.
    Applicants: Dominion Energy Marketing, Inc.
    Description: Amdmt to Pending Filing--Amndmt to Aug 30 2013 re:
Category Seller Status to be effective 10/1/2013.
    Filed Date: 4/21/14.
    Accession Number: 20140421-5223.
    Comments Due: 5 p.m. ET 5/12/14.

    Docket Numbers: ER14-706-001.
    Applicants: Midcontinent Independent System Operator, Inc.
    Description: 2014-04-22--Schedule 3 Compliance Filing Amendment re:
Order 784 to be effective 12/27/2013.
    Filed Date: 4/22/14.
    Accession Number: 20140422-5176.
    Comments Due: 5 p.m. ET 5/13/14.

    Docket Numbers: ER14-1751-000.
    Applicants: C2K Energy, LLC.
    Description: Application for Market Based Rate Authority to be
effective 6/21/2014.
    Filed Date: 4/22/14.
    Accession Number: 20140422-5059.
    Comments Due: 5 p.m. ET 5/13/14.

    Docket Numbers: ER14-1752-000.
    Applicants: Midcontinent Independent System Operator, Inc.
    Description: 2014-04-22 1st Quarter Tariff Pricing Clean-Up Filing
to be effective 4/23/2014.
    Filed Date: 4/22/14.
    Accession Number: 20140422-5155.
    Comments Due: 5 p.m. ET 5/13/14.

    Docket Numbers: ER14-1753-000.
    Applicants: Pacific Gas and Electric Company.
    Description: Notice of Termination of Hercules Municipal Utility IA
and WDT SAs to be effective 4/10/2014.
    Filed Date: 4/22/14.
    Accession Number: 20140422-5202.
    Comments Due: 5 p.m. ET 5/13/14.

    Take notice that the Commission received the following land
acquisition reports:
    Docket Numbers: LA14-1-000.
    Applicants: Virginia Electric and Power Company, Dominion Energy
Marketing, Inc., Dominion Nuclear Connecticut, Inc., Dominion Energy
Kewaunee, Inc., Dominion Energy Manchester Street, Inc., Dominion
Retail, Inc., Fairless Energy, LLC, NedPower Mount Storm, LLC, Fowler
Ridge Wind Farm LLC, Dominion Bridgeport Fuel Cell, LLC.
    Description: Quarterly Land Acquisition Report of Virginia Electric
and Power Company, et al. under LA14-1.
    Filed Date: 4/22/14.
    Accession Number: 20140422-5035.
    Comments Due: 5 p.m. ET 5/13/14.

    Take notice that the Commission received the following public
utility holding company filings:
    Docket Numbers: PH14-9-000.
    Applicants: Bloom Energy Companies.
    Description: Bloom Energy Companies submits FERC 65-B Waiver
Notification of Bloom Energy Corporation.
    Filed Date: 4/22/14.
    Accession Number: 20140422-5074.
    Comments Due: 5 p.m. ET 5/13/14.

    The filings are accessible in the Commission's eLibrary system by
clicking on the links or querying the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2014-09738 Filed 4-28-14; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 82, Number 11 (Wednesday, January 18, 2017)]
[Notices]
[Pages 5557-5558]
[FR Doc No: 2017-00925]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings #1

    Take notice that the Commission received the following electric
corporate filings:

    Docket Numbers: EC17-61-000.
    Applicants: Michigan Electric Transmission Company, LLC.
    Description: Application Pursuant to Section 203 of the Federal
Power Act of Michigan Electric Transmission Company, LLC.
    Filed Date: 1/9/17.
    Accession Number: 20170109-5366.
    Comments Due: 5 p.m. ET 1/30/17.

    Take notice that the Commission received the following electric
rate filings:

    Docket Numbers: ER10-3124-004; ER10-3129-004; ER10-3130-004; ER10-
3132-004; ER10-3134-004; ER10-3137-004; ER13-460-001.
    Applicants: Noble Altona Windpark, LLC, Noble Bliss Windpark, LLC,
Noble Clinton Windpark I, LLC, Noble

Chateaugay Windpark, LLC, Noble Ellenburg Windpark, LLC, Noble Great
Plains Windpark, LLC, Noble Wethersfield Windpark, LLC.
    Description: Notice of Non-Material Change in Status of the Noble
Sellers.
    Filed Date: 1/9/17.
    Accession Number: 20170109-5370.
    Comments Due: 5 p.m. ET 1/30/17.

    Docket Numbers: ER17-761-000.
    Applicants: ITC Midwest LLC.
    Description: Sec.  205(d) Rate Filing: Filing of a Joint Use Pole
Agreement with Northern States to be effective 3/10/2017.
    Filed Date: 1/9/17.
    Accession Number: 20170109-5320.
    Comments Due: 5 p.m. ET 1/30/17.

    Docket Numbers: ER17-762-000.
    Applicants: Southwest Power Pool, Inc.
    Description: Sec.  205(d) Rate Filing: 3293 Thunderhead Wind Energy
GIA to be effective 12/21/2016.
    Filed Date: 1/10/17.
    Accession Number: 20170110-5029.
    Comments Due: 5 p.m. ET 1/31/17.

    Docket Numbers: ER17-763-000.
    Applicants: Wabash Valley Power Association, Inc.
    Description: Sec.  205(d) Rate Filing: Formulary Rate Tariff
Depreciation Rates to be effective 1/10/2017.
    Filed Date: 1/10/17.
    Accession Number: 20170110-5039.
    Comments Due: 5 p.m. ET 1/31/17.

    The filings are accessible in the Commission's eLibrary system by
clicking on the links or querying the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: January 10, 2017.
Kimberly D. Bose,
Secretary.
[FR Doc. 2017-00925 Filed 1-17-17; 8:45 am]
 BILLING CODE 6717-01-P


[Federal Register Volume 82, Number 138 (Thursday, July 20, 2017)]
[Notices]
[Pages 33505-33507]
[FR Doc No: 2017-15204]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2017-N-3857]

Enhanced Drug Distribution Security Under the Drug Supply Chain
Security Act; Public Meetings; Request for Comments

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public meetings; request for comments.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA, the Agency, or we) is
announcing three public meetings entitled ``Enhanced Drug Distribution
Security Under the Drug Supply Chain Security Act (DSCSA).'' These
public meetings are intended to provide members of the pharmaceutical
distribution supply chain and other interested stakeholders an
opportunity to discuss with FDA, and provide input on, strategies and
issues related to the enhanced drug distribution security provisions of
the DSCSA.

DATES: The public meetings will be held on: August 23, 2017, from 9
a.m. to 4 p.m.; December 5 and 6, 2017, from 9 a.m. to 4 p.m.; and
February 28, 2018, from 9 a.m. to 4 p.m.

ADDRESSES: The public meetings will be held at FDA's White Oak Campus,
10903 New Hampshire Ave., Bldg. 31, Rm. 1503A, Silver Spring, MD 20993.
Entrance for the public meeting participants (non-FDA employees) is
through Building 1 where routine security check procedures will be
performed. For parking and security information, please refer to
https://www.fda.gov/AboutFDA/WorkingatFDA/BuildingsandFacilities/WhiteOakCampusInformation/ucm241740.htm.
    Comments: To permit the widest possible opportunity to obtain
public comment, FDA is soliciting either electronic or written comments
on all aspects of the public meeting topics. You may submit comments as
follows. Please note that the deadlines for submitting either
electronic or written comments are 30 days after the meeting to which
the comments relate. Comments received by mail/hand delivery/courier
(for written/paper

submissions) will be considered timely if they are postmarked or the
delivery service acceptance receipt is on or before that date. The
https://www.regulations.gov electronic filing system will accept
comments until midnight Eastern Time at the end of the specified date.
See the SUPPLEMENTARY INFORMATION section for registration dates and
for the deadlines for submitting electronic or written comments related
to these public meetings (table 1).

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No.
FDA-2017-N-3857 for ``Enhanced Drug Distribution Security Under the
Drug Supply Chain Security Act; Public Meetings; Request for
Comments.'' Received comments, those filed in a timely manner (see
ADDRESSES), will be placed in the docket and, except for those
submitted as ``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m.
and 4 p.m., Monday through Friday.
     Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Daniel Bellingham, Office of
Compliance, Center for Drug Evaluation and Research, Food and Drug
Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993, 301-
796-3130<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. Background

    On November 27, 2013, the Drug Supply Chain Security Act (DSCSA)
(Title II, Pub. L. 113-54) was signed into law. The DSCSA outlines
critical steps to build an electronic, interoperable system by 2023 to
identify and trace certain prescription drugs as they are distributed
within the United States. This system will enhance FDA's ability to
protect U.S. consumers from exposure to drugs that may be counterfeit,
diverted, stolen, intentionally adulterated, or otherwise harmful by
improving the detection and removal of potentially dangerous drugs from
the drug supply chain. Section 582(i) of the Federal Food, Drug, and
Cosmetic Act (21 U.S.C. 360eee-1(i)), which was added by the DSCSA,
directs FDA to hold public meetings to enhance the safety and security
of the pharmaceutical distribution supply chain and provide
opportunities for comment from stakeholders.

II. Purpose of the Public Meetings

    FDA will hold public meetings on August 23, 2017, December 5 and 6,
2017, and February 28, 2018, on enhanced drug distribution security.
The purpose of these public meetings is to provide members of the
pharmaceutical distribution supply chain and other interested
stakeholders an opportunity to discuss with FDA, and provide input on,
strategies and issues related to the enhanced drug distribution
security provisions of the DSCSA. These public meetings will focus on
the following topics for discussion:

 What supply chain security should look like in 2023
 What is needed for enhanced drug distribution security
 What is needed for electronic interoperability
 Standards for product tracing
 Data architecture options for an electronic interoperable
system
 The management and maintenance of product tracing data
 The use of aggregation and inference for enhanced product
tracing and verification
 Building capacity for a unit-level system for product tracing
and verification

    FDA may include additional discussion topics. Materials for each
public meeting will be provided on FDA's Web site at https://www.fda.gov/Drugs/NewsEvents/UCM559090.htm 10 days before each public
meeting.

III. Registration for the Public Meetings

    To request registration for the public meetings, provide your
information including name, company or organization, address, telephone
number, and email address to FDA at

https://www.fda.gov/Drugs/NewsEvents/UCM559090.htm. Registration
requests for each meeting should be received during the time periods
specified in table 1. FDA is limiting attendance due to restricted
space. In addition, FDA may limit the number of participants from each
organization based on space limitations. FDA recommends that each
organization determine who should register for the public meeting to
represent his/her organization. This will help ensure that the meeting
will have broad and varied representation, including across the
pharmaceutical distribution supply chain. Registrants will receive
confirmation of participation for their chosen meeting from FDA within
14 days of the date of each meeting. There is no registration fee for
the public meetings. There will be no onsite registration. If
registration reaches maximum capacity, FDA will post a notice closing
registration for the meeting on FDA's Web site at https://www.fda.gov/Drugs/NewsEvents/UCM559090.htm. If you need special accommodations due
to a disability, please contact Daniel Bellingham (see FOR FURTHER
INFORMATION CONTACT) at least 7 days in advance of the public meeting.

                                       Table 1--Public Meeting Information
----------------------------------------------------------------------------------------------------------------
                                                                                Relevant section of
            Public meeting                      Topics                 Date/Time             this document or
                                                                                electronic address
----------------------------------------------------------------------------------------------------------------
# 1..................................   Supply chain    August 23, 2017, 9 a.m.
                                        security in 2023.        to 4 p.m.
                                        Enhanced drug
                                        distribution security
                                        needs.
                                       Advance registration...  by July 31, 2017.......  Online registration
                                                                                only at https://www.fda.gov/Drugs/NewsEvents/UCM559090.htm. No
                                                                                onsite registration.
                                       Comment period closes..  September 22, 2017.....  See ``Comments''.
                                       Request special          by August 16, 2017.....  See FOR FURTHER
                                        accommodations due to                             INFORMATION CONTACT.
                                        a disability.
# 2..................................   Electronic      December 5-6, 2017, 9
                                        interoperability.        a.m. to 4 p.m.
                                        Standards for
                                        data exchange.
                                        Data
                                        architecture.
                                        Aggregation
                                        and inference.
                                       Advance registration...  October 2-27, 2017.....  Online registration
                                                                                only at https://www.fda.gov/Drugs/NewsEvents/UCM559090.htm. No
                                                                                onsite registration.
                                       Comment period closes..  January 5, 2018........  See ``Comments''.
                                       Request special          by November 28, 2017...  See FOR FURTHER
                                        accommodations due to                             INFORMATION CONTACT.
                                        a disability.
# 3..................................   Further         February 28, 2018, 9
                                        refinement of enhanced   a.m. to 4 p.m.
                                        drug distribution
                                        security needs.
                                        Building
                                        capacity for a unit-
                                        level system.
                                       Advance registration...  January 2-26, 2018.....  Online registration
                                                                                only at https://www.fda.gov/Drugs/NewsEvents/UCM559090.htm. No
                                                                                onsite registration.
                                       Comment period closes..  March 30, 2018.........  See ``Comments''.
                                       Request special          by February 21, 2018...  See FOR FURTHER
                                        accommodations due to                             INFORMATION CONTACT.
                                        a disability.
----------------------------------------------------------------------------------------------------------------

IV. Webcasting of the Public Meeting

    Portions of each public meeting will be recorded and webcast on the
day of the meeting. Information for how to access the webcast will be
available at https://www.fda.gov/Drugs/NewsEvents/UCM559090.htm within
7 days prior to each public meeting. The webcast will be conducted in
listening mode only.

    Dated: July 14, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning, Legislation, and Analysis.
[FR Doc. 2017-15204 Filed 7-19-17; 8:45 am]
 BILLING CODE 4164-01-P


[Federal Register Volume 82, Number 189 (Monday, October 2, 2017)]
[Rules and Regulations]
[Page 45729]
[FR Doc No: 2017-21041]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Coast Guard

33 CFR Part 165

[Docket No. USCG-2015-1081]

Safety Zones; Annual Events Requiring Safety Zones in the Captain
of the Port Lake Michigan Zone--Corn Festival Fireworks

AGENCY: Coast Guard, DHS.

ACTION: Notice of enforcement of regulation.

-----------------------------------------------------------------------

SUMMARY: The Coast Guard will enforce a safety zone on the Illinois
River in Morris, IL. This action is necessary and intended to ensure
the safety of life and property on navigable waters before, during, and
immediately after a shore based firework display. During the
enforcement period listed below, vessels and persons are prohibited
from transiting through, mooring, or anchoring within this safety zone
without approval from the Captain of the Port Lake Michigan or his or
her designated representative.

DATES: The regulations in 33 CFR 165.929 will be enforced for the
location listed in item (h)(1) in Table 165.929 to 33 CFR 165.929 from
8:15 p.m. until 9:25 p.m. on September 30, 2017.

FOR FURTHER INFORMATION CONTACT: If you have questions about this
notice of enforcement, call or email LT John Ramos, Waterways
Management Division, Marine Safety Unit Chicago, at<PHONE_NUMBER>, email
address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: The Coast Guard will enforce the safety zone
listed in 33 CFR 165.929: Safety Zone; Corn Festival Fireworks listed
as item (h)(1) in Table 165.929 of 33 CFR 165.929. Section 165.929
lists many annual events requiring safety zones in the Captain of the
Port Lake Michigan zone. This safety zone will encompass all waters of
the Illinois River within an 560 foot radius from approximate launch
position at 41[deg]21.173' N. 88[deg]25.101' W. (NAD 83). This safety
zone will be enforced on September 30, 2017 from 8:15 p.m. until 9:25
p.m.
    All vessels must obtain permission from the Captain of the Port
Lake Michigan, or his or her designated on-scene representative to
enter, move within, or exit this safety zone during the enforcement
times listed in this notice of enforcement. All requests must be made
in advance and approved by the Captain of the Port Lake Michigan before
transits will be authorized. Approvals for entry will be granted on a
case-by-case basis. All vessels and persons granted permission to enter
the safety zone shall obey all lawful orders or directions of the
Captain of the Port Lake Michigan, or his or her on-scene
representative.
    This notice of enforcement is issued under authority of 33 CFR
165.929, Safety Zones; Annual events requiring safety zones in the
Captain of the Port Lake Michigan zone, and 5 U.S.C. 552(a). In
addition to this publication in the Federal Register, the Coast Guard
will provide the maritime community with advance notification of this
enforcement period via Broadcast Notice to Mariners and Local Notice to
Mariners. The Captain of the Port Lake Michigan or a designated on-
scene representative may be contacted via VHF Channel 16 during the
event.

    Dated: September 26, 2017.
Thomas J. Stuhlreyer,
Captain, U.S. Coast Guard, Captain of the Port Lake Michigan.
[FR Doc. 2017-21041 Filed 9-29-17; 8:45 am]
 BILLING CODE 9110-04-P